Nomura Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,692
| Closed | -$560K | – | 1055 |
|
|
2025
Q1 | $560K | Buy |
+1,692
| New | +$560K | ﹤0.01% | 788 |
|
|
2024
Q4 | – | Sell |
-1,394
| Closed | -$296K | – | 1605 |
|
|
2024
Q3 | $296K | Buy |
+1,394
| New | +$296K | ﹤0.01% | 747 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1248 |
|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$231K | – | 972 |
|
|
2023
Q2 | $231K | Buy |
+1,000
| New | +$231K | ﹤0.01% | 619 |
|
|
2020
Q2 | – | Sell |
-3,500
| Closed | -$233K | – | 899 |
|
|
2020
Q1 | $233K | Buy |
+3,500
| New | +$233K | ﹤0.01% | 457 |
|
|
2019
Q3 | – | Sell |
-27,500
| Closed | -$2.91M | – | 861 |
|
|
2019
Q2 | $2.91M | Buy |
+27,500
| New | +$2.91M | 0.01% | 343 |
|
|
2015
Q4 | – | Sell |
-4,187
| Closed | -$254K | – | 1480 |
|
|
2015
Q3 | $254K | Buy |
4,187
+433
| +12% | +$26.3K | ﹤0.01% | 903 |
|
|
2015
Q2 | $292K | Buy |
+3,754
| New | +$292K | ﹤0.01% | 1129 |
|
|
2015
Q1 | – | Sell |
-3,182
| Closed | -$300K | – | 1496 |
|
|
2014
Q4 | $300K | Sell |
3,182
-7,819
| -71% | -$737K | ﹤0.01% | 1163 |
|
|
2014
Q3 | $1.17M | Buy |
11,001
+1,814
| +20% | +$193K | ﹤0.01% | 709 |
|
|
2014
Q2 | $1.31M | Buy |
9,187
+330
| +4% | +$47.2K | ﹤0.01% | 695 |
|
|
2014
Q1 | $1.36M | Buy |
8,857
+1,846
| +26% | +$283K | ﹤0.01% | 815 |
|
|
2013
Q4 | $1.28M | Buy |
7,011
+4,566
| +187% | +$832K | 0.01% | 793 |
|
|
2013
Q3 | $538K | Buy |
2,445
+612
| +33% | +$135K | ﹤0.01% | 1265 |
|
|
2013
Q2 | $319K | Buy |
+1,833
| New | +$319K | ﹤0.01% | 1479 |
|